Inhibition of inner ear ornithine decarboxylase by neomycin in-vitro. BRAIN RES BULL 19(6) [695][696][697][698] 1987.-We quantitated the activity of omithine decarboxylase (ODC) in homogenates and subcellular fractions of inner ear tissues from the rat and guinea pig and demonstrate inhibition of cochlear ODC by the aminoglycoside neomycin. Subcellular fractionation showed the enzyme associated with the postmitochondrial supematant fraction in each of the tissues: Specific activities of ODC, defined as cr-difluoromethylomithine (DFMO)-sensitive decar~xylatio~ of ornithine, in the supematant fractions of combined inner ear tissues were: guinea pig=4424 pmoles CO, produce~hour/mg protein, and rat= 133130. In the guinea pig, supernatant fractions of the lateral wall tissues (stria vascularis and spiral ligament) had specific activities of 62-e25, those of the organ of Corti (plus VIIIth nerve) 64~41. The ototoxic aminoglycoside neomycin produced a dose-dependent inhibition of ODC with half-maximal inhibition observed at 50 PM drug and almost complete inhibition at 100 PM. This is the first report of the presence of ODC in the inner ear and its inhibition by neomycin. Since both the ODC-inhibitors, DFMO and neomycin, can cause hearing loss in patients and experimental animals it is suggested that inhibition of ODC may be an important factor in the ototoxicity of these drugs.
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Omithine decarboxylase
Difluoromethylornithine Neomycin Ototoxicity Inner ear Cochlea ORNITHINE decarboxylase (ODC), a ubiquitous enzyme regulating the biosynthesis of the polyamines putrescine, spermidine and spermine, plays a major role in cellular growth, development, maintenance and regeneration [IZ] . Interest in this enzyme and the polyamines in the inner ear arises from clinical observations that administration of the antitumor and antiprotozoal agent a-difluoromethylomithine (DFMO), an irreversible inhibitor of ODC, has led to hearing loss in patients receiving the drug [l, 2, 171. In addition, a number of observations suggest that interactions between the ototoxic and nephrotoxic aminogIycosides and polyamines may contribute to the toxicity of these drugs. For example, we have demonstrated the inhibition of renal ODC activity by aminoglycoside antibiotics (Henley et al. in preparation) and competition for polyamine transport in the inner ear [21] . In addition, the polyamines compete with aminoglycosides for renal binding and uptake fS,9].
ODC has not been documented in the inner ear. Although a recent study detected the polyamines spermidine and spermine in the cochlea of rats, neither putrescine nor ODC activity was found [ 151. We demonstrate that ODC is present in the tissues of the rat and guinea pig cochlea and that the enzyme is inhibited in a dose-dependent manner by the ototoxic aminogiycoside neomycin.
METHOD
Sprague-Dawley rats (18&200 g; Charles River Laboratories, Wilmington, MA) or pigmented guinea pigs (approximately 250 g; Murphy Breeding Laboratories, Plainsfield, IN) were briefly anesthetized with ether. Following cardiac perfusion with phosphate-buffered saline (PBS) at room temperature to flush the cochlear blood vessels the animals were decapitated and the auditory bullae removed. Each bulla was then opened to expose the cochlea. At this time the cochlea was perfused with an ice cold Ringer's solution containing 2 mM dithioerythritol (DTE), 50 PM pyridoxal phosphate (PLP) and 10 PM phenylmethylsulfonyluoride (PMSF; a protease inhibitor) from the round window to an exit hole in the apex. The cochlear bone was then removed under a dissecting microscope and the inner ear tissues dissected at 4°C in PBS containing 10 PM PMSF.
Tissues from both the right and left ears were combined and homogenized in 60 to 140 ~1 of ice cold 50 mM HEPES (N-Zhydroxyethyl-1-piperazine-N*-Zethanesulfonic acid), pH 7.2, 2 mM DTE, 50 PM PLP and 10 ,uM PMSF. The total homogenate, ~stmito~hondri~ supematant (13OOOxg for 20 min at 4°C) and the resuspended pelleted fractions were analyzed for ODC activity. ODC was assayed by a modification of the procedure by Russell and Snyder filter disks saturated with 40% KOH. Radioactivity on the filters was quantitated by liquid scintillation counting. For each experiment, control incubations for nonenzymati~ and nonspecific decarboxylation were performed by adding 500 PM DFMO (nonspecific) to the assays or substituting 20 pg bovine serum albumin (BSA; nonenzymatic) for the tissue. DFMG insensitive activity (nonspecific decarboxylation) was defined as the difference in activity between incubations in the presence of DFMO and incubations with BSA. ODC activity was defined as the DFMO-sensitive decarboxylation of ornithine.
DFMO was a gift from Merrell Dow Research Institute (Cincinnati, OH). Other chemicals were purchased from Sigma Chemical Company (St. Louis, MO).
RESULTS

ODC Activity in Combined Inner Ear Tissues
ODC activity was measured in homogenates and subcellular fractions of the inner ear tissues of both the rat and guinea pig. In homogenates of combined inner ear tissues, mean specific activities of ODC were 134 pmoles CO.Jhr/mg protein for the rat and 22 for the guinea pig (Table 1 , last column). In addition, considerable nonspecific decarboxylation of ornithine (not related to ODC) was evident: 46+ 16 in rat and 5% 1 in the guinea pig (Table 1 , + DFMO).
Subsequent examination of subcellular fractions demonstrated that ODC was associated only with the postmitochondrial supematant fraction (Table 1) : 133230 pmoles CO, in the rat and 44k4 in the guinea pig and no activity in the pellet. Fu~he~ore, nonspecifk decarboxylation (+ DFMO) was negligible (rat, 2-c2; guinea pig, OrtO) in the supematant . In contrast, decarboxylation of omithine by the resuspended pelleted fractions was not inhibited by 500 FM DFMO.
ODC Activity in Individual Cochlear Tissues
ODC was subsequently examined in dissected structures of the guinea pig inner ear, namely the tissues of the lateral wall (stria vascularis & spiral ligament) and the organ of Corti (including VIIIth nerve fibers). Total homogenates as well as the supematant and pelleted fractions were assayed (Table 1) . Activity attributable to ODC in tissue homogenates was 62r5 pmoles CO$hr/mg protein for the lateral wall and 341-10 for the organ of Corti (Table 1, Column 3). As with the combined inner ear tissues, a considerable nonspecific decarboxylation (not sensitive to inhibition by DFMO) of omithine was also observed (Table 1 , + DFMO).
For the prep~ation of subcellular fractions from separated tissues six ears were pooled in order to achieve a high protein concentration.
Specific activity of ODC was 62*25 for lateral wall and 64541 for organ of Corti (Table 1 , Column 3). Protein concentrations in assays with six pooled ears averaged 2% pg/ml for the lateral wall tissues and 172 *g/ml for the organ of Cork Maintenance of a high protein concentration was essential since loss of ODC activity resulted Ornithine decarboxylase activity was assayed as described in the Method section. All values are corrected for non-enzymatic decarboxylation (i.e., BSA-blanks are subtracted). ODC is defined as "DFMO-Sensitive activity," i.e., total activity (-DFMO) minus nonspecific activity (+ DFMO). Values are means * standard errors from (n) independent experiments in which duplicate or triplicate assays were performed.
when tissues from only two pooled ears was assayed. In such a case, activity in the stria vascularis and spiral ligament was low (544 pmoles COdhrlmg protein) and in the organ of Corti it was nondetectable.
In agreement with the results from the combined ear tissues, no significant ODC activity was present in the pelleted fractions of the individual tissues.
Neomycin Inhibition of Cochlear ODC
Inhibition of ODC by neomycin was studied in the postmitochondrial supernatant fractions of combined inner ear tissues. Final concentrations of neomycin varied from 1 PM to 1 mM and duplicate or triplicate incubations were performed in parallel with control incubations with and without DFMO. Neomycin produced a dose-dependent inhibition of cochlear ODC. Activity was reduced to 54*5% in the presence of 50 PM neomycin and almost completely inhibited by 100 PM neomycin.
DISCUSSION
The study clearly demonstrates the presence of ODC activity in the tissues of the inner ear of both the rat and the guinea pig. The reason why the specific activity is significantly higher in the rat remains speculative. Higher ODC activities are generally found during development but the animals used here should be considered mature. Nevertheless, age may have been a factor since preliminary studies in the young (10 and 11 days) hooded rat showed up to ten-fold higher cochlear ODC activity (Henley et al., unpublished) and the postnatal developmental pattern of ODC and polyamines in cochlear tissues has not been characterized.
Guinea pigs were chosen for the detailed studies of ODC since the species is ideally suited for surgical access to the cochlea and subsequent dissection of its tissues [4] . More importantly, the guinea pig yields greater amounts of tissue from the inner ear. For example, while combined tissues from one rat cochlea provided 12 to 33 pg protein, yield from the guinea pig was two-to three-fold greater providing 58 to 80 pg. This is an important consideration since ODC is extremely labile in the presence of low protein concentrations [lo, 12, 161 and sensitive to dilution during all stages of purification procedures [7] . In fact, ODC activity was more consistently detected in the guinea pig than in the rat. In addition to the experiments reported in Table 1 , four incubations with rat tissues (out of a total of 15) did not show activity, whereas in the guinea pig only two incubations (out of a total of 46) failed to detect ODC. The necessity for maintaining higher protein concentrations became evident again when supernatant fractions of individual tissues were assayed. These results confirm the requirement for adequate protein concentrations to stabilize the enzyme. This instability of ODC may have contributed to the inability of Schweitzer et al. [ 151 to detect this enzyme in the inner ear.
The clinical use of DFMO in cancer chemotherapy and aminoglycosides in the treatment of bacterial infections has resulted in loss of hearing. The demonstration of DFMOsensitive ODC in cochlear tissues and its inhibition by neomycin agrees well with our previous findings of aminoglycosideipolyamine antagonism {21]. It suggests that ODC and polyamine-regulated cellular functions may be targets of these drugs. While the mechanism of DFMO ototoxicity is unknown, a tenable hypothesis has been offered for aminoglycoside ototoxicity [ 141 including a possible action on ODC. The enzyme may not necessarily be the primary site of drug action but it is suggested that drug effects on polyamine synthesis and function potentiate the injury induced by aminoglycosides. It is well established that drug-induced or other noxious insults to a target cell may result in induction of ODC and polyamine synthesis as part of a compensatory repair mechanism 13, 6, 7, 221. Thus, inhibition of a recovery response by the aminoglycoside itself could contribute to cell death.
A similar argument can be made for the known potentiation of noise-induced cochlear damage by aminoglycosides. Noise-induced cellular damage may be followed by induction of ODC in tissue recovery. Aminoglycoside inhibition of ODC would block this repair process. Another example for a possibly critical role of ODC as a drug target is the develop- While the role of ODC in drug-induced ototoxicity remains speculative the proposed mechanisms are testable and interesting in view of the crucial involvement of ODC in cellular regulation. The fact that two distinctly different ototoxic drugs inhibit this enzymatic activity is highly intriguing.
